0001144204-13-004103.txt : 20130125 0001144204-13-004103.hdr.sgml : 20130125 20130125181123 ACCESSION NUMBER: 0001144204-13-004103 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130123 FILED AS OF DATE: 20130125 DATE AS OF CHANGE: 20130125 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Conover Charles CENTRAL INDEX KEY: 0001538563 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-12957 FILM NUMBER: 13549817 MAIL ADDRESS: STREET 1: 20 KINGSBRIDGE ROAD CITY: PISCATAWAY STATE: NJ ZIP: 08854 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENZON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000727510 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 222372868 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 20 KINGSBRIDGE ROAD STREET 2: ATT: GENERAL COUNSEL CITY: PISCATAWAY STATE: NJ ZIP: 08854 BUSINESS PHONE: 732-980-4500 MAIL ADDRESS: STREET 1: 20 KINGSBRIDGE ROAD STREET 2: ATT: GENERAL COUNSEL CITY: PISCATAWAY STATE: NJ ZIP: 08854 FORMER COMPANY: FORMER CONFORMED NAME: ENZON PHARMACEUTICALS INC DATE OF NAME CHANGE: 20021211 FORMER COMPANY: FORMER CONFORMED NAME: ENZON PHARMACEUTICAL INC DATE OF NAME CHANGE: 20021210 FORMER COMPANY: FORMER CONFORMED NAME: ENZON INC DATE OF NAME CHANGE: 19920703 4 1 v333066_4.xml OWNERSHIP DOCUMENT X0306 4 2013-01-23 0 0000727510 ENZON PHARMACEUTICALS INC ENZN 0001538563 Conover Charles C/O ENZON PHARMACEUTICALS, INC. 20 KINGSBRIDGE ROAD PISCATAWAY NJ 08854 0 1 0 0 SVP, R&D Program Management Common Stock 2013-01-23 4 A 0 2343 0 A 74793 D This Form 4 is being filed to report the accelerated vesting of 2,343 restricted stock units (RSUs) that were originally granted to the Reporting Person on August 12, 2011. The August 12, 2011 grant consisted of 7,028 RSUs, which vest in full on August 12, 2014 if the Reporting Person remains employed by the Issuer on such date, provided that 50% of the RSUs are subject to accelerated vesting upon the achievement of certain performance milestones. Certain of the performance milestones applicable to the RSU grant were achieved, resulting in the accelerated vesting of 2,343 of the RSUs on January 23, 2013. Because the RSUs granted to the Reporting Person on August 12, 2011 were previously included in the number of shares of common stock reported as beneficially owned by the Reporting Person, the accelerated vesting of 2,343 of the RSUs did not affect the number of shares reported as beneficially owned. All RSU amounts in this Form 4 reflect an equitable adjustment approved by the Compensation Committee and made to the Issuer's outstanding RSUs in connection with the special cash dividend of $2.00 per share paid by the Issuer on December 21, 2012 to stockholders of record as of December 10, 2012. /s/ Andrew Rackear, Attorney-in-Fact 2013-01-25